期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Paracrine Fibroblast Growth Factor-Based Therapy:An Unexpected Panacea for Metabolic-DysfunctionAssociated Fatty Liver Disease(MAFLD)
1
作者 Tongtong Pan Ting Li +2 位作者 Lu Shi lihuang su Yongping Chen 《Infectious Microbes & Diseases》 2022年第1期13-19,共7页
Metabolic-dysfunction-associated fatty liver disease(MAFLD)is a group of highly heterogeneous multi-system diseases,which is closely related to metabolic dysfunction and is one of the most important public health prob... Metabolic-dysfunction-associated fatty liver disease(MAFLD)is a group of highly heterogeneous multi-system diseases,which is closely related to metabolic dysfunction and is one of the most important public health problems in the world.Studies have shown that paracrine fibroblast growth factors(FGFs)play an important role in the occurrence and development of MAFLD by regulating glucose and lipid metabolism,inflammation,and fibrosis.This article reviews the latest progress in understanding of the distribution,function,and metabolic regulation of paracrine FGFs,which paves the way for future FGF-based therapies targeting MAFLD. 展开更多
关键词 fibroblast growth factor metabolic-dysfunction-associated fatty liver disease PARACRINE metabolic regulation
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部